CC
MRNA icon

Centiva Capital’s Moderna MRNA Stock Holding History

Centiva Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,733
Closed -$139K – 2095
2026
Q1 		$139K Buy
+2,733
New +$128K ﹤0.01% 1342
2025
Q3 		– Sell
-6,311
Closed -$174K – 1573
2025
Q2 		$174K Buy
+6,311
New +$166K ﹤0.01% 1363
2024
Q4 		– Sell
-4,568
Closed -$218K – 2141
2024
Q3 		$305K Sell
4,568
-5
-0.1% -$459 0.01% 1572
2024
Q2 		$543K Buy
+4,573
New +$579K 0.01% 1104
2024
Q1 		– Sell
-918
Closed -$91.3K – 2061
2023
Q4 		$91.3K Buy
918
+643
+234% +$54.1K ﹤0.01% 1597
2023
Q3 		$28.4K Sell
275
-18,112
-99% -$2.02M ﹤0.01% 1630
2023
Q2 		$2.23M Buy
18,387
+8,242
+81% +$1.1M 0.05% 345
2023
Q1 		$1.56M Sell
10,145
-5,613
-36% -$926K 0.04% 482
2022
Q4 		$2.83M Sell
15,758
-3,780
-19% -$618K 0.08% 263
2022
Q3 		$2.31M Buy
19,538
+18,728
+2,312% +$2.84M 0.04% 315
2022
Q2 		$116K Sell
810
-33,574
-98% -$4.8M ﹤0.01% 1402
2022
Q1 		$5.92M Buy
+34,384
New +$5.79M 0.11% 132
2021
Q4 		– Sell
-1,229
Closed -$359K – 1423
2021
Q3 		$473K Buy
+1,229
New +$453K 0.03% 638
2021
Q2 		– Sell
-16,922
Closed -$3.02M – 1529
2021
Q1 		$2.22M Buy
+16,922
New +$2.45M 0.08% 183
2020
Q3 		– Sell
-4,133
Closed -$265K – 818
2020
Q2 		$265K Buy
+4,133
New +$226K 0.02% 437

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Centiva Capital's MRNA Position: Q2 2026 in Review

Centiva Capital sold out of Moderna (MRNA) in Q2 2026, closing a stake of 2,733 shares — an estimated $139K sold.

Centiva Capital first reported a position in MRNA in Q2 2020 and held it in 15 quarters. The position peaked at $5.92M in Q1 2022. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Centiva Capital reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 2,733 Moderna shares in Q2 2026, an estimated $139K.
  • Centiva Capital first reported a position in Moderna in Q2 2020 and held it in 15 quarters.
  • Centiva Capital's Moderna position peaked at $5.92M in Q1 2022.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.